Latest stories on ONC
BeOne Medicines presents new data across solid tumor disease areas at ESMO 2026
The Fly58 · neutralproduct/pr
BeOne Medicines Says Esophageal Cancer Treatments Had Higher Survival Rates in Phase 3 Study
MarketWatch74 · bullishproduct/pr
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
StockTitan64 · neutralproduct/pr
BeOne Medicines: Brukinsa And Tevimbra Face A High Bar
Seeking Alpha42 · neutralanalyst
BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 5
StockTitan50 · neutralgeneral
ONCOR TO RELEASE THIRD QUARTER 2026 RESULTS NOVEMBER 5
StockTitan50 · neutralearnings
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
StockTitan63 · neutralproduct/pr
BeOne Medicines price target raised to $425 from $405 at Morgan Stanley
The Fly63 · neutralanalyst
BeOne Medicines price target raised to $459 from $450 at RBC Capital
The Fly61 · neutralanalyst
BeOne Medicines price target raised to $420 from $418 at Truist
The Fly63 · neutralanalyst
BeOne Medicines price target raised to $445 from $425 at JPMorgan
The Fly63 · neutralanalyst
BeOne Medicines AG (ONC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
BeOne Medicines price target raised to $415 from $407 at Barclays
The Fly63 · neutralanalyst
FDA Approval Marks A Turning Point For BeOne Medicines (ONC)
Yahoo Top88 · bullishproduct/pr
BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
StockTitan56 · neutralgeneral
Trump Administration Reaches Most-Favored-Nation Drug Pricing Deals With 9 Companies
Morningstar50 · neutralpotus
BeOne Medicines to expand access to cancer medicines under pact with U.S.
The Fly63 · neutralproduct/pr
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
StockTitan63 · neutralgeneral
BeOne Medicines announces new Phase 3 survival data on Ziihera
The Fly63 · neutralproduct/pr
BeOne Medicines Ltd. (BEIGF) files 8-K
SEC 8-K50 · neutralgeneral
JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy
Stocktwits News67 · bullishproduct/pr
BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
StockTitan73 · bullishproduct/pr
BeOne Medicines Takes Aim at Hard-To-Treat Childhood Leukemia With New Sonrotoclax Trial
TipRanks63 · neutralproduct/pr